Clinical Trial Update: Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 clinical trial is evaluating sirolimus for idiopathic retroperitoneal fibrosis, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Retroperitoneal Fibrosis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Peking University International Hospital | Conditions: Retroperitoneal Fibrosis | Phase 2, Phase 3 | Status: RECRUITING